The study was designed as a pilot trial and included a relatively small number of participants, limiting its ability to detect differences in major outcomes such as death or hospitalization
Mol Neurobiol 61(5):24692480
Pharmacokinetics: Data indicate a linear pharmacokinetic profile with a short half-life ( 1000mcg/day) have been anecdotally associated with increased chances of headaches, fatigue, or water retention, and may lead to diminishing returns, suggesting a bell-shaped dose-response curve
According to the DoDs Operation Supplement Safety (OPSS) program, BPC-157: Is not authorized for use by Service Members and is considered a prohibited substance. This classification places BPC-157 on the same level as SARMs and other unapproved substances that are banned for military personnel due to lack of safety, purity concerns, and performance-altering effects
Licensed Peptides supplies research-grade MTII designed exclusively for laboratory use